Publications

  1. Chopra A, Tye SJ, Lee KH, Sampson S, Matsumoto J, Adams A, Klassen B, Stead M, Fields JA, Frye MA. Underlying neurobiology and clinical correlates of mania status after subthalamic nucleus deep brain stimulation in Parkinson's disease: a review of the literature. J Neuropsychiatry Clin Neurosci. 2012 Winter; 24(1):102-10. 2238269
    View PubMed
  2. Adeli A, Savica R, Lowe VJ, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Crum BA, Jack CR, Petersen RC, Boeve BF. The GGGGCC Repeat Expansion in C9ORF72 in a Case with Discordant Clinical and FDG-PET Findings: PET Trumps Syndrome. Neurocase. 2012 Nov 30. [Epub ahead of print] 2287755
    View PubMed
  3. Savica R, Adeli A, Vemuri P, Knopman DS, Dejesus-Hernandez M, Rademakers R, Fields JA, Whitwell J, Jack CR, Lowe V, Petersen RC, Boeve BF. Characterization of a family with c9FTD/ALS associated with the GGGGCC repeat expansion in C9ORF72. Arch Neurol. 2012 Sep; 69(9):1164-9. 2276590
    View PubMed
  4. McDade EM, Boeve BF, Fields JA, Kumar N, Rademakers R, Baker MC, Knopman BD, Petersen RC, Jack CR Jr, Kantarci K. MRS in Early and Presymptomatic Carriers of a Novel Octapeptide Repeat Insertion in the Prion Protein Gene. J Neuroimaging. 2012 May 21. [Epub ahead of print] 2247793
    View PubMed
  5. McDade E, Boeve BF, Burrus TM, Boot BP, Kantarci K, Fields J, Lowe VJ, Peller P, Knopman D, Baker M, Finch N, Rademakers R, Petersen R. Similar clinical and neuroimaging features in monozygotic twin pair with mutation in progranulin. Neurology. 2012 Apr 17; 78(16):1245-9. Epub 2012 Apr 04. 2241157
    View PubMed
  6. Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain. 2012 Mar; 135(Pt 3):765-83. 2227707
    View PubMed
  7. Fields JA, Ferman TJ, Boeve BF, Smith GE. Neuropsychological assessment of patients with dementing illness. Nat Rev Neurol. 2011 Dec; 7(12):677-87. Epub 2011 Nov 01. 2203526
    View PubMed
  8. Kumar N, Boeve BF, Boot BP, Orr CF, Duffy J, Woodruff BK, Nair AK, Ellison J, Kuntz K, Kantarci K, Jack CR Jr, Westmoreland BF, Fields JA, Baker M, Rademakers R, Parisi JE, Dickson DW. Clinical characterization of a kindred with a novel 12-octapeptide repeat insertion in the prion protein gene. Arch Neurol. 2011 Sep; 68(9):1165-70. 2190687
    View PubMed
  9. Fields JA, Machulda M, Aakre J, Ivnik RJ, Boeve BF, Knopman DS, Petersen RC, Smith GE. Utility of the DRS for predicting problems in day-to-day functioning. Clin Neuropsychol. 2010 Oct; 24(7):1167-80. 2118619
    View PubMed
  10. Weiner MF, de la Plata CM, Fields JA, Womack KB, Rosenberg RN, Gong Y-H, Qu B-X, Diaz-Arrastia R, Hynan LS. Brain MRI, apolipoprotein E genotype, and plasma homocysteine in American Indian Alzheimer disease patients and Indian controls. Curr Alzheimer Res. 2009 Feb; 6(1):52-8. 2251869
  11. Weiner M, Fields J, Hynan L, Cullum CM. Annualized functional change in Alzheimer's disease participants and normal controls. Clin Neuropsychol. 2008 Sep; 22(5):801-6. 2251861
  12. Weiner MF, Rosenberg RN, Womack KB, Svetlik DA, Fuller C, Fields J, Hynan LS. Atherosclerosis risk factors in American Indians with Alzheimer disease: preliminary findings. Alzheimer Dis Assoc Disord. 2008 Jul-Sep; 22(3):245-8. 2251864
  13. Woods SP, Scott JC, Fields JA, Poquette A, Tröster AI. Executive dysfunction and neuropsychiatric symptoms predict lower health status in essential tremor. Cogn Behav Neurol. 2008 Mar; 21(1):28-33. 2251860
  14. Borson S, Scanlan J, Friedman S, Zuhr E, Fields J, Aylward E, Mahurin R, Richards T, Anzai Y, Yukawa M, Yeh S. Modeling the impact of COPD on the brain. Int J Chron Obstruct Pulmon Dis. 2008; 3(3):1-6. 2251866
  15. Allen G, Barnard H, McColl R, Hester AL, Fields JA, Weiner MF, Ringe WK, Lipton AM, Brooker M, McDonald E, Rubin CD, Cullum CM. Reduced hippocampal functional connectivity in Alzheimer disease. Arch Neurol. 2007 Oct; 64(10):1482-7. 2251858
  16. Tröster AI, Fields JA, Paolo AM, Koller WC. Absence of the apolipoprotein E epsilon4 allele is associated with working memory impairment in Parkinson's disease. J Neurol Sci. 2006 Oct 25; 248(1-2):62-7. 2251854
  17. Unützer J, Tang L, Oishi S, Katon W, Williams JW Jr, Hunkeler E, Hendrie H, Lin EH, Levine S, Grypma L, Steffens DC, Fields J, Langston C. Reducing suicidal ideation in depressed older primary care patients J Am Geriatr Soc. 2006 Oct; 54(10):1550-6. 2251856
  18. Tröster AI, Pahwa R, Fields JA, Tanner CM, Lyons KE. Quality of life in Essential Tremor Questionnaire (QUEST): development and initial validation. Parkinsonism Relat Disord. 2005 Sep; 11(6):367-73. 2251851
  19. Piatt AL, Fields JA, Paolo AM, Tröster AI. Action verbal fluency normative data for the elderly. Brain Lang. 2004 Jun; 89(3):580-3. 2251850
  20. Woods SP, Fields JA, Lyons KE, Pahwa R, Tröster AI. Pulse width is associated with cognitive decline after thalamic stimulation for essential tremor. Parkinsonism Relat Disord. 2003 Jun; 9(5):295-300. 2251846
  21. Croyle KL, Tröster AI, Fields JA, Straits-Tröster KA, Lyons KE, Pahwa R. Presurgical coping, depression, and quality of life in persons with Parkinson's disease. J Clin Psychol Med Settings. 2003 Jun; 10(2):101-7. 2251849
  22. Fields JA, Tröster AI, Woods SP, Higginson CI, Wilkinson SB, Lyons KE, Koller WC, Pahwa R. Neuropsychological and quality of life outcomes 12 months after unilateral thalamic stimulation for essential tremor. J Neurol Neurosurg Psychiatry. 2003 Mar; 74(3):305-11. 2251843
  23. Tröster AI, Fields JA, Wilkinson S, Pahwa R, Koller WC, Lyons KE. Effect of motor improvement on quality of life following subthalamic stimulation is mediated by changes in depressive symptomatology. Stereotact Funct Neurosurg. 2003; 80(1-4):43-7. 2251844
  24. Tröster AI, Woods SP, Fields JA. Verbal fluency declines after pallidotomy: an interaction between task and lesion laterality. Appl Neuropsychol. 2003; 10(2):69-75. 2251845
  25. Norman S, Tröster AI, Fields JA, Brooks R. Effects of depression and Parkinson's disease on cognitive functioning. J Neuropsychiatry Clin Neurosci. 2002 Winter; 14(1):31-6. 2251839
  26. Tröster AI, Woods SP, Fields JA, Hanisch C, Beatty WW. Declines in switching underlie verbal fluency changes after unilateral pallidal surgery in Parkinson's disease. Brain Cogn. 2002 Nov; 50(2):207-17. 2251840
  27. Woods SP, Fields JA, Tröster AI. Neuropsychological sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a critical review. Neuropsychol Rev. 2002 Jun; 12(2):111-26. 2251842
  28. Tröster AI, Woods SP, Fields JA, Lyons KE, Pahwa R, Higginson CI, Koller WC. Neuropsychological deficits in essential tremor: an expression of cerebello-thalamo-cortical pathophysiology? Eur J Neurol. 2002 Mar; 9(2):143-51. 2251841
  29. Woods SP, Fields JA, Lyons KE, Koller WC, Wilkinson SB, Pahwa R, Tröster AI. Neuropsychological and quality of life changes following unilateral thalamic deep brain stimulation in Parkinson's disease: a one-year follow-up. Acta Neurochir (Wien). 2001 Dec; 143(12 Discussion 8):1273-7. 2251835
  30. Higginson CI, Fields JA, Koller WC, Tröster AI. Questionnaire assessment potentially overestimates anxiety in Parkinson's disease. J Clin Psychol Med Settings. 2001 Jun; 8(2):95-9. 2251837
  31. Higginson CI, Fields JA, Tröster AI. Which symptoms of anxiety diminish after surgical interventions for Parkinson disease? Neuropsychiatry Neuropsychol Behav Neurol. 2001 Apr-Jun; 14(2):117-21. 2251832
  32. Straits-Tröster K, Fields JA, Wilkinson SB, Pahwa R, Lyons KE, Koller WC, Tröster AI. Health-related quality of life in Parkinson's disease after pallidotomy and deep brain stimulation. Brain Cogn. 2000 Apr; 42(3):399-416. 2251831
  33. Fields JA, Tröster AI. Cognitive outcomes after deep brain stimulation for Parkinson's disease: a review of initial studies and recommendations for future research. Brain Cogn. 2000 Mar; 42(2):268-93. 2251830
  34. Piatt AL, Fields JA, Paolo AM, Tröster AI. Action (verb naming) fluency as an executive function measure: convergent and divergent evidence of validity. Neuropsychologia. 1999 Dec; 37(13):1499-503. 2251825
  35. Troster AI, Fields JA, Pahwa R, Wilkinson SB, Strait-Troster KA, Lyons K, Kieltyka J, Koller WC. Neuropsychological and quality of life outcome after thalamic stimulation for essential tremor. Neurology. 1999 Nov 10; 53(8):1774-80. 2251827
    View PubMed
  36. Fields JA, Tröster AI, Wilkinson SB, Pahwa R, Koller WC. Cognitive outcome following staged bilateral pallidal stimulation for the treatment of Parkinson's disease. Clin Neurol Neurosurg. 1999 Sep; 101(3):182-8. 2251821
  37. Piatt AL, Fields JA, Paolo AM, Koller WC, Tröster AI. Lexical, semantic, and action verbal fluency in Parkinson's disease with and without dementia. J Clin Exp Neuropsychol. 1999 Aug; 21(4):435-43. 2251824
  38. Tröster AI, Wilkinson SB, Fields JA, Miyawaki K, Koller WC. Chronic electrical stimulation of the left ventrointermediate (Vim) thalamic nucleus for the treatment of pharmacotherapy-resistant Parkinson's disease: a differential impact on access to semantic and episodic memory? Brain Cogn. 1998 Nov; 38(2):125-49. 2251815
  39. Testa JA, Tröster AI, Fields JA, Gleason AC, Salmon DP, Beatty WW. Semantic fluency performance of patients with cortical and subcortical neurodegenerative diseases. Aging Neuropsychol Cogn. 1998 Sep; 5(3):203-14. 2251819
  40. Tröster AI, Fields JA, Testa JA, Paul RH, Blanco CR, Hames KA, Salmon DP, Beatty WW. Cortical and subcortical influences on clustering and switching in the performance of verbal fluency tasks. Neuropsychologia. 1998 Apr; 36(4):295-304. 2251812
  41. Tröster AI, Fields JA, Wilkinson SB, Pahwa R, Miyawaki E, Lyons KE, Koller WC. Unilateral pallidal stimulation for Parkinson's disease: neurobehavioral functioning before and 3 months after electrode implantation. Neurology. 1997 Oct; 49(4):1078-83. 2251809
  42. Tröster AI, Fields JA, Wilkinson SB, Busenbark K, Miyawaki E, Overman J, Pahwa R, Koller WC. Neuropsychological functioning before and after unilateral thalamic stimulating electrode implantation in Parkinson's disease. Neurosurgical FOCUS. 1997; 2(3):E11. 2251810
  43. Tröster AI, Osorio I, Fields JA, Lai CW, Eckard DA, Preston DF, Whitaker HA. Transient alexia (letter-by-letter reading) after single photon emission computed tomography-verified selective left posterior cerebral artery sodium amytal injection. Neuropsychiatry Neuropsychology and Behavioral Neurology. 1996 Jul; 9(3):209-17. 2251801
  44. Tröster AI, Fields JA, Paolo AM, Koller WC. Performance of individuals with Parkinson's disease on the Vocabulary and Information subtests of the WAIS-R as a Neuropsychological Instrument. J Clin Geropsychology. 1996; 2:215-23. 2251802
  45. Tröster AI, Stalp L, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson's disease with and without depression. Parkinson/Alzheimer Digest. 1996; 5:5-7. 2251808
  46. Tröster AI, Stalp LD, Paolo AM, Fields JA, Koller WC. Neuropsychological impairment in Parkinson's disease with and without depression. Arch Neurol. 1995 Dec; 52(12):1164-9. 2251791
  47. Tröster AI, Fields JA. Frontal cognitive function and memory in Parkinson's disease: Toward a distinction between prospective and declarative memory impairments. Alzheimer Dis Assoc Disord. 1995; 8(2):59-74. 2251796